Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Abingdon Health PLC ( (GB:ABDX) ) just unveiled an announcement.
Abingdon Health PLC announced it will release its unaudited interim results for the six months ending December 31, 2024, on March 24, 2025. The company will host a live investor presentation on March 26, 2025, open to existing and potential shareholders. This announcement underscores Abingdon Health’s commitment to transparency and engagement with its stakeholders, potentially impacting its market positioning by enhancing investor relations and confidence.
More about Abingdon Health PLC
Abingdon Health PLC is a leading med-tech contract service provider with an international customer base. The company specializes in lateral flow product development, regulatory support, technology transfer, and manufacturing services for various sectors, including infectious disease, clinical testing, animal health, and environmental testing. Abingdon Health also offers regulatory services through Compliance Solutions and IVDeology, supporting the in vitro diagnostic and medical device industries. Additionally, the company provides self-tests through its Abingdon Simply Test e-commerce platform, offering consumers tools to manage their health and wellbeing.
YTD Price Performance: -12.90%
Average Trading Volume: 116,209
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £13.07M
For an in-depth examination of ABDX stock, go to TipRanks’ Stock Analysis page.